Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 3Urinary Bladder Neoplasms 1Thrombosis 1Thrombocytopenia 1Sarcoma 1Pulmonary Embolism 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hematoma 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Bone Neoplasms 1

Interventions

Tretinoin 2apixaban 1Tranexamic Acid 1Tinzaparin 1Sirolimus 1Pluvicto 1Observation 1Enoxaparin 1Dalteparin 1Algorithms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × Enoxaparin × 1 year × Clear all
NCT05255003 2025-12-17

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Ottawa Hospital Research Institute

Phase 4 Recruiting
50 enrolled
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡